Instituto de Diagnóstico Past Earnings Performance
Past criteria checks 1/6
Instituto de Diagnóstico's earnings have been declining at an average annual rate of -10.4%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 9% per year. Instituto de Diagnóstico's return on equity is 0.1%, and it has net margins of 0.07%.
Key information
-10.4%
Earnings growth rate
-10.4%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 9.0% |
| Return on equity | 0.1% |
| Net Margin | 0.07% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Slowing Rates Of Return At Instituto de Diagnóstico (SNSE:INDISA) Leave Little Room For Excitement
Sep 07
Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly
Aug 17A Look At The Intrinsic Value Of Instituto de Diagnóstico S.A. (SNSE:INDISA)
May 19Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly
Apr 16Instituto de Diagnóstico (SNSE:INDISA) Will Will Want To Turn Around Its Return Trends
May 06Is Instituto de Diagnóstico S.A. (SNSE:INDISA) A Strong Dividend Stock?
Mar 23Instituto de Diagnóstico S.A.'s (SNSE:INDISA) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?
Mar 02Is Instituto de Diagnóstico (SNSE:INDISA) Using Too Much Debt?
Feb 09
Should We Be Excited About The Trends Of Returns At Instituto de Diagnóstico (SNSE:INDISA)?
Jan 25Instituto de Diagnóstico's(SNSE:INDISA) Share Price Is Down 37% Over The Past Three Years.
Jan 07Should You Use Instituto de Diagnóstico's (SNSE:INDISA) Statutory Earnings To Analyse It?
Dec 23What Kind Of Shareholders Own Instituto de Diagnóstico S.A. (SNSE:INDISA)?
Dec 06Are Poor Financial Prospects Dragging Down Instituto de Diagnóstico S.A. (SNSE:INDISA Stock?
Nov 20Revenue & Expenses BreakdownBeta
How Instituto de Diagnóstico makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 218,934 | 144 | 40,688 | 0 |
| 30 Sep 23 | 208,743 | -1,754 | 40,773 | 0 |
| 30 Jun 23 | 200,653 | 651 | 37,957 | 0 |
| 31 Mar 23 | 193,826 | 4,658 | 34,640 | 0 |
| 31 Dec 22 | 191,288 | 13,050 | 32,555 | 0 |
| 30 Sep 22 | 191,914 | 18,867 | 30,076 | 0 |
| 30 Jun 22 | 192,568 | 21,805 | 30,453 | 0 |
| 31 Mar 22 | 190,227 | 21,850 | 28,671 | 0 |
| 31 Dec 21 | 188,543 | 20,650 | 28,235 | 0 |
| 30 Sep 21 | 181,911 | 18,459 | 26,791 | 0 |
| 30 Jun 21 | 168,991 | 14,035 | 25,301 | 0 |
| 31 Mar 21 | 149,224 | 6,804 | 24,768 | 0 |
| 31 Dec 20 | 139,356 | 3,501 | 23,951 | 0 |
| 30 Sep 20 | 132,991 | 2,140 | 24,037 | 0 |
| 30 Jun 20 | 136,848 | 4,661 | 23,823 | 0 |
| 31 Mar 20 | 148,687 | 10,383 | 24,958 | 0 |
| 31 Dec 19 | 150,185 | 11,630 | 24,540 | 0 |
| 30 Sep 19 | 152,074 | 12,081 | 24,587 | 0 |
| 30 Jun 19 | 151,180 | 12,613 | 24,206 | 0 |
| 31 Mar 19 | 147,859 | 14,820 | 23,530 | 0 |
| 31 Dec 18 | 145,411 | 14,695 | 23,726 | 0 |
| 30 Sep 18 | 143,492 | 14,809 | 24,262 | 0 |
| 30 Jun 18 | 141,367 | 14,435 | 24,091 | 0 |
| 31 Mar 18 | 140,188 | 12,115 | 23,961 | 0 |
| 31 Dec 17 | 138,351 | 11,888 | 23,384 | 0 |
| 30 Sep 17 | 135,533 | 11,850 | 21,728 | 0 |
| 30 Jun 17 | 133,502 | 11,803 | 21,824 | 0 |
| 31 Mar 17 | 129,985 | 11,646 | 21,656 | 0 |
| 31 Dec 16 | 128,308 | 12,934 | 20,979 | 0 |
| 30 Sep 16 | 126,478 | 14,209 | 20,006 | 0 |
| 30 Jun 16 | 122,922 | 14,049 | 19,061 | 0 |
| 31 Mar 16 | 120,250 | 13,816 | 18,338 | 0 |
| 31 Dec 15 | 116,942 | 13,132 | 17,625 | 0 |
| 30 Sep 15 | 112,666 | 11,958 | 17,668 | 0 |
| 30 Jun 15 | 108,732 | 11,545 | 17,096 | 0 |
| 31 Mar 15 | 105,763 | 11,332 | 16,857 | 0 |
| 31 Dec 14 | 103,628 | 11,730 | 16,628 | 0 |
| 30 Sep 14 | 100,967 | 11,673 | 16,088 | 0 |
| 30 Jun 14 | 98,049 | 11,446 | 15,506 | 0 |
| 31 Mar 14 | 95,307 | 11,138 | 14,723 | 0 |
| 31 Dec 13 | 92,299 | 10,588 | 13,882 | 0 |
| 30 Sep 13 | 89,311 | 9,849 | 13,203 | 0 |
| 30 Jun 13 | 85,571 | 9,061 | 12,381 | 0 |
Quality Earnings: INDISA has high quality earnings.
Growing Profit Margin: INDISA's current net profit margins (0.07%) are lower than last year (6.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INDISA's earnings have declined by 10.4% per year over the past 5 years.
Accelerating Growth: INDISA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: INDISA had negative earnings growth (-98.9%) over the past year, making it difficult to compare to the Healthcare industry average (17.1%).
Return on Equity
High ROE: INDISA's Return on Equity (0.1%) is considered low.